Advanced Resin Therapeutics Overview

  • Founded
  • 1999
  • Status
  • Private
  • Employees
  • 2
  • Latest Deal Type
  • Later Stage VC
  • (Cancelled)
  • Latest Deal Amount
  • $2.5M
Latest Deal Amount
  • Investors
  • 2

Advanced Resin Therapeutics General Information


Operator of a specialty pharmaceutical company intended to conduct research and development of a resin, trans-mucosal systemic delivery of active ingredients focused on the central nervous system. The company's formulations are designed to provide quick delivery of alprazolam for anxiety, ondansetron for nausea, sumatriptan for migraines, fentanyl for pain, Vardenafil and Sildenafil for erectile dysfunction and nicotine as an aid to smoking cessation, providing medical practitioners with a delivery system that promotes topical and transmucosal delivery of medications more efficiently and effectively than current technologies.

Contact Information

Formerly Known As
Jaleva Pharmaceuticals
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Delivery
Other Industries
Drug Discovery
Primary Office
  • 13073 Signature Point
  • Suite 202
  • San Diego, CA 92130
  • United States
+1 (858) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Advanced Resin Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Later Stage VC $2.5M Cancelled Generating Revenue
3. Later Stage VC (Series 1) 03-Apr-2017 00.00 00.000 00.00 Completed Generating Revenue
2. Accelerator/Incubator 12-May-2016 $454K Completed Generating Revenue
1. Later Stage VC 27-May-2011 $454K $454K Completed Generating Revenue
To view Advanced Resin Therapeutics’s complete valuation and funding history, request access »

Advanced Resin Therapeutics Cap Table

Stock # of Shares
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series 1 0,000,000 00.000000 00 00.00 00.00 00 00.00 00.000
To view Advanced Resin Therapeutics’s complete cap table history, request access »

Advanced Resin Therapeutics Executive Team (5)

Name Title Board Seat Contact Info
Howard Edelman Chief Executive Officer
Tracey Forester Chief Marketing Officer
Alex Battaglia Ph.D Co-Founder, Chief Science Officer & Board Member
Eva Beim Co-Founder, Executive Vice President of Strategic Relations and Global Business Development
You’re viewing 4 of 5 executive team members. Get the full list »

Advanced Resin Therapeutics Board Members (2)

Name Representing Role Since
Alex Battaglia Ph.D Advanced Resin Therapeutics Co-Founder, Chief Science Officer & Board Member 000 0000
You’re viewing 1 of 2 board members. Get the full list »

Advanced Resin Therapeutics Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Advanced Resin Therapeutics Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
CONNECT (Accelerator) Accelerator/Incubator Minority 000 0000 000000 0
Button Capital Venture Capital Minority 000 0000 000000 0
To view Advanced Resin Therapeutics’s complete investors history, request access »